|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2006-11-10
|
|
pubmed:abstractText |
The prognosis of esophageal cancer is not only affected by TNM stage but also by the level of serum vascular endothelial growth factor (S-VEGF). This study was to investigate the effect of concurrent chemoradiotherapy on S-VEGF in esophageal squamous cell carcinoma (ESCC), and to explore the correlation of S-VEGF to the prognosis of ESCC.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1428-32
|
|
pubmed:meshHeading |
pubmed-meshheading:17094915-Adolescent,
pubmed-meshheading:17094915-Adult,
pubmed-meshheading:17094915-Aged,
pubmed-meshheading:17094915-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17094915-Carcinoma, Squamous Cell,
pubmed-meshheading:17094915-Cisplatin,
pubmed-meshheading:17094915-Disease-Free Survival,
pubmed-meshheading:17094915-Drug Administration Schedule,
pubmed-meshheading:17094915-Esophageal Neoplasms,
pubmed-meshheading:17094915-Female,
pubmed-meshheading:17094915-Fluorouracil,
pubmed-meshheading:17094915-Humans,
pubmed-meshheading:17094915-Male,
pubmed-meshheading:17094915-Middle Aged,
pubmed-meshheading:17094915-Radiotherapy, High-Energy,
pubmed-meshheading:17094915-Remission Induction,
pubmed-meshheading:17094915-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
|
|
pubmed:affiliation |
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
